Literature DB >> 22160831

Eosinophilic disorders in various diseases.

Jocelyn Celestin1, Marianne Frieri.   

Abstract

Peripheral and tissue eosinophilia are usually associated with a variety of inflammatory, malignant, and infectious conditions. As the presence of eosinophils in the tissues may cause significant cellular damage to vital organs such as the heart, tissue eosinophilia should be diagnosed and treated promptly. One operative way to evaluate eosinophilic disorders is to classify them into extrinsic and intrinsic. While extrinsic eosinophilic disorders are usually due to the production of eosinopoietic factors derived from T cells or tumor cells, the intrinsic types generally are the result of genetic mutations in the eosinophilic lineage. As we understand more the biology of eosinophils, only a few eosinophilic disorders remain idiopathic. The purpose of this article is to help the clinician classify in an operational manner most eosinophilic disorders, using the extrinsic and intrinsic model. This may facilitate not only a better understanding of the role of eosinophils in these disorders, but also help the systematic clinical work-up and potential treatment of affected patients.

Entities:  

Mesh:

Year:  2012        PMID: 22160831     DOI: 10.1007/s11882-011-0240-5

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  44 in total

Review 1.  Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

Review 2.  Epidemiologic, clinical, and diagnostic aspects of coccidioidomycosis.

Authors:  Michael A Saubolle; Peter P McKellar; Den Sussland
Journal:  J Clin Microbiol       Date:  2006-11-15       Impact factor: 5.948

Review 3.  Biology and treatment of eosinophilic esophagitis.

Authors:  Marc E Rothenberg
Journal:  Gastroenterology       Date:  2009-08-15       Impact factor: 22.682

4.  Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia.

Authors:  M Samoszuk; L Nansen
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

5.  Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

Authors:  M J Leckie; A ten Brinke; J Khan; Z Diamant; B J O'Connor; C M Walls; A K Mathur; H C Cowley; K F Chung; R Djukanovic; T T Hansel; S T Holgate; P J Sterk; P J Barnes
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

6.  Myeloproliferative disorder with eosinophilia and ETV6-ABL gene rearrangement: efficacy of second-generation tyrosine kinase inhibitors.

Authors:  Ranveer Nand; Christine Bryke; Steven H Kroft; Ajit Divgi; Christopher Bredeson; Ehab Atallah
Journal:  Leuk Res       Date:  2009-04-25       Impact factor: 3.156

Review 7.  Recent advances in pathogenesis and management of hypereosinophilic syndromes.

Authors:  F Roufosse; E Cogan; M Goldman
Journal:  Allergy       Date:  2004-07       Impact factor: 13.146

Review 8.  Eosinophilic leukaemia.

Authors:  Sarah Fletcher; Barbara Bain
Journal:  Br Med Bull       Date:  2007-04-18       Impact factor: 4.291

Review 9.  Chronic myelocytic leukemia with eosinophilia, t(9;12)(q34;p13), and ETV6-ABL gene rearrangement: case report and review of the literature.

Authors:  Yi Kong Keung; Michael Beaty; William Steward; Bethy Jackle; Mark Pettnati
Journal:  Cancer Genet Cytogenet       Date:  2002-10-15

10.  Lymphocyte Rich Hodgkin's Lymphoma Presented with Warm Hemolytic Anemia: A Case Report and Literature Review.

Authors:  Jorge M Hurtado-Cordovi; Vaibhav Verma; Vladimir Gotlieb; Marianne Frieri
Journal:  Case Rep Hematol       Date:  2011-09-28
View more
  4 in total

1.  Understanding allergic multimorbidity within the non-eosinophilic interactome.

Authors:  Daniel Aguilar; Nathanael Lemonnier; Gerard H Koppelman; Erik Melén; Baldo Oliva; Mariona Pinart; Stefano Guerra; Jean Bousquet; Josep M Anto
Journal:  PLoS One       Date:  2019-11-06       Impact factor: 3.240

2.  Gene therapy in a murine model of chronic eosinophilic leukemia-not otherwise specified (CEL-NOS).

Authors:  Odelya E Pagovich; Katie M Stiles; Anna E Camilleri; Anthony R Russo; Saparja Nag; Ronald G Crystal
Journal:  Leukemia       Date:  2021-09-20       Impact factor: 11.528

3.  Eosinophil chemotactic chemokine profilings of the brain from permissive and non-permissive hosts infected with Angiostrongylus cantonenis.

Authors:  Shuting Li; Fan Yang; Pengyu Ji; Xin Zeng; Xiaoying Wu; Jie Wei; Lisi Ouyang; Jinyi Liang; Huanqin Zheng; Zhongdao Wu; Zhiyue Lv
Journal:  Parasitol Res       Date:  2014-02       Impact factor: 2.289

Review 4.  Mechanisms controlling mast cell and basophil lineage decisions.

Authors:  Hua Huang; Yapeng Li
Journal:  Curr Allergy Asthma Rep       Date:  2014-09       Impact factor: 4.806

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.